Document Classification

Section Type: RESULTS

Text: After 8 weeks, significantly greater proportions of patients treated with olmesartan medoxomil 20mg achieved 24-hour and daytime ABPM goals recommended by the guidelines of the ESH/ESC (25. 6 % and 18. 3 %, respectively) and JSH (37. 5 % and 26. 6 %, respectively) compared with candesartan cilexetil 8mg (24-hour ESH/ESC goal = 14. 9 %, p < 0. 001 ; 24-hour JSH goal = 26. 6 %, p = 0. 003 ; daytime ESH/ESC goal = 9. 6 %, p = 0. 002 ; daytime JSH goal = 16. 4 %, p = 0. 002).